Evaluation of anti-Yersinia psueudotuberculosis-derived mitogen antibody in intravenous immunoglobulin products.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 06 04 2022
revised: 20 07 2022
accepted: 27 07 2022
pubmed: 8 8 2022
medline: 14 9 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

Antibody titers against the superantigen, Yersinia pseudotuberculosis-derived mitogen, suggestive of mediating Kawasaki disease-like manifestation in Y. pseudotuberculosis infections, in immunoglobulin products were evaluated. Trace, but detectable titer was demonstrated in the products. Thus, attention is required when evaluating anti-Y. pseudotuberculosis-derived mitogen IgG titers in patient sera post intravenous immunoglobulin therapy.

Identifiants

pubmed: 35934232
pii: S1341-321X(22)00216-1
doi: 10.1016/j.jiac.2022.07.020
pii:
doi:

Substances chimiques

Immunoglobulins, Intravenous 0
Mitogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1582-1583

Informations de copyright

Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest IM received lecture fee from Nihon Pharmaceutical Co., Ltd.

Auteurs

Ippei Miyata (I)

Department of Pediatrics, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama, 7010192, Japan. Electronic address: miyata.kkcl@gmail.com.

Atsushi Kato (A)

Department of Pediatrics, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama, 7010192, Japan.

Kazunobu Ouchi (K)

Department of Medical Welfare for Children, Faculty of Health and Welfare, Kawasaki University of Medical Welfare, 288 Matsushima, Kurashiki City, Okayama, 7010193, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH